Individual Stock News:
1. Yuejiang (02432.HK): Proposes A-share listing on the Shenzhen Stock Exchange.
2. Country Garden (02007.HK): The company has set December 30, 2025 as the effective date for its restructuring.
3. Grand Pharmaceutical (00512.HK): The world's first approved adrenaline nasal spray, Youminsu, has been approved for marketing in China.
4. UBTECH (09880.HK): Chairman Zhou Jian has committed to a 12-month ban on the sale of his company shares.
5. China Duty Free Group (01880.HK): Its wholly-owned subsidiary signed a contract for a duty-free project at Beijing Capital International Airport.
6. Tiande Chemical (00609.HK): Plans to acquire a 49% stake in its non-wholly-owned subsidiary, Weifang Zhongying Chemical, for RMB 88 million. 7. Leapmotor (09863.HK): 4.139 million H shares will be released from lock-up under the incentive plan and will be sold on the secondary market at opportune times.
8. CSPC Pharmaceutical Group (01093.HK): Prudgliptin, dapagliflozin, and metformin extended-release tablets have received clinical trial approval in China.
9. HKR International (00480.HK): HKR International plans to sell all issued share capital of Yueshan Limited for HK$452 million.
10. Ganfeng Lithium (01772.HK): The company is suspected of insider trading and has received a notice of prosecution from the Yichun Public Security Bureau.
11. Zhipu Huazhang (02513.HK): Plans to issue over 37 million shares in its Hong Kong IPO, priced at HK$116.2.
12. Tianshu Zhixin (09903.HK): Plans to issue over 25 million shares in its Hong Kong IPO, priced at HK$144.6.
